| Griffiths-Jones S, Saini HK, van Dongen S, et al. Mirbase:Tools for microrna genomics[J]. Nucleic Acids Res, 2008, 36:D154-158. Schratt G. Fine-tuning neural gene expression with micrornas[J]. Curr Opin Neurobiol, 2009, 19:213-219. Sempere LF, Freemantle S, Pitha-Rowe I, et al. Expression profiling of mammalian micrornas uncovers a subset of brain-expressed micrornas with possible roles in murine and human neuronal differentiation[J]. Genome Biol, 2004, 5:R13. Mishima T, Mizuguchi Y, Kawahigashi Y, et al. Rt-pcr-based analysis of microrna(mir-1 and -124) expression in mouse cns[J]. Brain Res, 2007, 1131:37-43. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some micrornas downregulate large numbers of target mrnas[J]. Nature, 2005, 433:769-773. Park CS, Tang SJ. Regulation of microrna expression by induction of bidirectional synaptic plasticity[J]. J Mol Neurosci, 2009, 38:50-56. Rajasethupathy P, Fiumara F, Sheridan R, et al. Characterization of small rnas in aplysia reveals a role for mir-124 in constraining synaptic plasticity through creb[J]. Neuron, 2009, 63:803-817. Tan JR, Koo YX, Kaur P, et al. MicroRNAs in stroke pathogenesis[J]. Curr Mol Med, 2011, 11:76-92. Dharap A, Bowen K, Place R, et al. Transient focal ischemia induces extensive temporal changes in rat cerebral micrornaome[J]. J Cereb Blood Flow Metab, 2009, 29:675-687. Yin KJ, Deng Z, Huang H, et al. Mir-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia[J]. Neurobiol Dis, 2010, 38:17-26. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microrna regulates dendritic spine development[J]. Nature, 2006, 439:283-289. Giannakakis A, Sandaltzopoulos R, Greshock J, et al. Mir-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer[J]. Cancer Biology and Therapy, 2008, 7:255-264. Fasanaro P, D'Alessandra Y, Di Stefano V, et al. Microrna-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-a3[J]. J Biol Chem, 2008, 283:15878-15883. Cheng AM, Byrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNAs in cell growth and apoptosis[J]. Nucleic Acids Res, 2005, 33:1290-1297. Soriano MA, Tessier M, Certa U, et al. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia[J]. J Cereb Blood Flow Metab, 2000, 20:1045-1055. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs:Association with disease and potential use as biomarkers[J]. Crit Rev Oncol Hematol, 2011, 2:193-208. Gan CS, Wang CW, Tan KS, et al. Circulatory microRNA-145 expression is increased in cerebral ischemia[J]. Genet Mol Res, 2012, 1:147-152. Jeyaseelan K, Lim KY, Armugam A. Microrna expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion[J]. Stroke, 2008, 39:959-966. Tan KS, Armugam A, Sepramaniam S, et al. Expression profile of micrornas in young stroke patients[J]. PLoS One, 2009, 4:e7689. Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology[J]. Physiol Genomics, 2011, 10:521-528. Weng H, Shen C, Hirokawa G, et al. Plasma miR-124 as a biomarker for cerebral infarction[J]. Biomed Res, 2011, 2:135-141. Zeng L, Liu J, Wang Y, et al. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia[J]. Front Biosci(Elite Ed). 2011, 3:1265-1272. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microrna expression profiling of ischemic stroke,intracerebral hemorrhage, and kainate seizures[J]. J Cereb Blood Flow Metab, 2010, 30:92-101. Bonauer A, Carmona G, Iwasaki M, et al. Microrna-92a controls angiogenesis and functional recovery of ischemic tissues in mice[J]. Science, 2009, 324:1710-1713. Ji R, Cheng Y, Yue J, et al. Microrna expression signature and antisense-mediated depletion reveal an essential role of microrna in vascular neointimal lesion formation[J]. Circ Res, 2007, 100:1579-1588. Yin KJ, Deng Z, Hamblin M, et al. Peroxisome proliferator-activated receptor delta regulation of mir-15a in ischemia-induced cerebral vascular endothelial injury[J]. J Neurosci, 2010, 30:6398-6408. Weyrich AS, Lindemann S, Tolley ND, et al. Change in protein phenotype without a nucleus:Translational control in platelets[J]. Semin Thromb Hemost, 2004, 30:491-498. Landry P, Plante I, Ouellet DL, et al. Existence of a microrna pathway in anucleate platelets[J]. Nat Struct Mol Biol, 2009, 16:961-966. Dangwal S, Thum T. MicroRNAs in platelet biogenesis and function[J]. Thromb Haemost, 2012, 4:599-604. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia:From experimental strategies to clinical use[J]. Lancet Neurol, 2009, 8:398-412. Barone FC, White RF, Spera PA, et al. Ischemic preconditioning and brain tolerance:Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression[J]. Stroke, 1998, 29:1937-1950. Stenzel-Poore MP, Stevens SL, Xiong Z, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia:Similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states[J]. Lancet, 2003, 362:1028-1037. Lusardi TA, Farr CD, Faulkner CL, et al. Ischemic preconditioning regulates expression of micrornas and a predicted target, mecp2, in mouse cortex[J]. J Cereb Blood Flow Metab, 2010, 30:744-756. Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral micrornas that are upstream to neuroprotective signaling pathways[J]. Journal of Neurochemistry, 2010, 113:1685-1691. Nan X, Cross S, Bird A. Gene silencing by methyl-cpg-binding proteins[J]. Novartis Found Symp, 1998, 214:6-16; discussion 16-21, 46-50. Chahrour M, Jung SY, Shaw C, et al. Mecp2, a key contributor to neurological disease, activates and represses transcription[J]. Science, 2008, 320:1224-1229. Hite KC, Adams VH, Hansen JC. Recent advances in mecp2 structure and function[J]. Biochem Cell Biol, 2009, 87:219-227. Gonzales ML, LaSalle JM. The role of mecp2 in brain development and neurodevelopmental disorders[J]. Curr Psychiatry Rep, 2010, 12:127-134. Wang L, Li H, Chen Q, et al. Wnt signaling stabilizes the dixdc1 protein through decreased ubiquitin-dependent degradation[J]. Cancer Science, 2010, 101:700-706. Sakurai M, Ayukawa K, Setsuie R, et al. Ubiquitin c-terminal hydrolase l1 regulates the morphology of neural progenitor cells and modulates their differentiation[J]. Journal of Cell Science, 2006, 119:162. Maysami S, Lan JQ, Minami M, et al. Proliferating progenitor cells:A required cellular element for induction of ischemic tolerance in the brain[J]. J Cereb Blood Flow Metab, 2008, 28:1104-1113. Jackson RJ, Standart N. How do micrornas regulate gene expression?[J]. Sci STKE, 2007, 367:re1. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of micrornas in vivo with 'antagomirs'[J]. Nature, 2005, 438:685-689. Ouyang YB, Lu Y, Yue S, et al. miR-181 regulates GRP78 and in fluences outcome from cerebral ischemiain vitro and in vivo[J]. Neurobiology D, 2012, 45:555-563. Chen J, Yang T, Yu H, et al. A functional variant in the 3'-utr of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microrna 211[J]. Human Molecular Genetics, 2010, 19:2524-2533. |
